The link between obesity and multiple disease comorbidities is well established. In 2003,
Calle and colleagues presented the relationship between obesity and several cancer types …

It is now established that obesity is related to a higher incidence of cancer during a lifespan.
The effective treatment of obesity opens up new perspectives in the treatment of a relevant …

Obesity and breast cancer are two major health issues that could be categorized as sincere
threats to human health. In the last few decades, the relationship between obesity and …

Background: Obesity is a chronic disease associated with increased morbidity and mortality
due to its complications. The aims of obesity treatment are primarily to accomplish weight …

This study aims to explore the anti-proliferative, pro-apoptotic, and anti-migration activities of
liraglutide (LGT) in MCF-7 breast cancer (BC) cells in subjects with obesity, particularly its …

Purpose Patients undergoing axillary lymph node dissection (ALND) for breast cancer face a
high risk of lymphedema, further increased by high body mass index (BMI) and insulin …

Diabetes mellitus (DM) is a significant risk factor for various cancers, with the impact of anti-
diabetic therapies on cancer progression differing across malignancies. Among these …

Introduction: Lymphedema is a major public health issue for many women undergoing
breast cancer treatment. Although weight loss has been reported to be beneficial in the …

Previously, we reported that glucagon-like peptide-1 (GLP-1) and its analog liraglutide could
inhibit fat de novo synthesis in the liver and reduce abdominal fat accumulation in broiler …

Cancer is a major cause of death in patients with diabetes. Incretin therapy has received
much attention because of its tissue-protective effects. We have previously reported an anti …